Ex vivo efficacy of gemifloxacin in experimental keratitis induced by methicillin-resistant Staphylococcus aureus
详细信息    查看全文
文摘

Ex vivo efficacy of 0.3% gemifloxacin (GFX) against MRSA-induced keratitis was evaluated.

GFX was the most efficient fluoroquinolone assayed in vitro.

Ex vivo results predicted that GFX may be an effective topical therapy.

Dose–response efficacy showed good performance at lower concentrations.

The ex vivo model has been enabled to mimic in vivo bacterial infection.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700